B-type natriuretic peptide (BNP) and high-sensitive C-reactive protein (hs-CRP) have provided some prognostic information in various populations, and recently, highly sensitive troponin (hs-TnT) and markers of cardiac fibrosis, such as sST2 and galectin-3, have shown promising results in risk assessment of cardiovascular events in patients with CAD and congestive heart failure (CHF)[6–12]. This evidence concerns the gene CRP and coronary artery disorder.